Federal contract award
75F40124C00087
BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $48.4K |
| Current contract value | $48.4K |
| Potential contract value / ceiling | $48.4K |
| Start date | Aug 15, 2024 |
| Current end date | Mar 7, 2025 |
| Potential end date | Mar 7, 2025 |
| Latest award activity | May 11, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 11, 2026 | P00002 | $-195.0K | BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONS: TERMINIATION FOR CONVENIENCE - FY26 UDO INITIATIVE |
| Mar 7, 2025 | P00001 | $0 | BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONS: EOI:: IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE :: EOI |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.